Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
What's New
Your Valuation
🇳🇦 NA Market
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Industry
Any
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
🌎
Switch to Global Market
Author Program
NEW
Create Narrative
Community
/
Namibia
/
Real Estate Management and Development
Real Estate Management and Development Namibian Community
Our community narratives are driven by numbers and valuation.
Author Program
NEW
Create Narrative
Real Estate Management and Development Namibian Investing Ideas
Popular
Undervalued
Overvalued
There are no community narratives available.
Top Authors
7d
30d
90d
All time
Author
Views
BL
BlackGoat
8.3k
HE
HedgeY
7.3k
BE
benjamin_lvieq
6.7k
WE
WealthAP
6.5k
TR
tripledub
5k
View top authors
Top watchlists
Watchlist
Views
SI
Beyond the Moon - 20 compelling space companies!
singhappily
•
20 companies
11.4k
View
TI
TSY's Top 30 Stocks - 2026
tickersymbolyou
•
30 companies
2.3k
View
TR
Everyday Moats
tripledub
•
20 companies
1.8k
View
IN
Brands at Right Price
Investingwilly
•
20 companies
1.7k
View
AN
Bio Tech Plays. Mispricing
AnimalDoctorKwon
•
19 companies
1.7k
View
View top watchlists
Recently
Updated Narratives
AS
AstrisCorporateAdvisory
on Macnica Holdings
·
Updated
34min ago
Sustainable growth on the cards
Fair Value:
JP¥2.61k
19.7% overvalued
intrinsic discount
1
fair value set
users have set this as their fair value
0
comments
users have commented on this narrative
0
likes
users have liked this narrative
DI
divine_4y1uv
on Robo.ai
·
Updated
1h ago
Robo.ai Appoints Former INTERPOL President H.E. Dr. Ahmed Naser Al-Raisi as Chairman of Its Subsidiary Alif Holding
Fair Value:
US$0.0027
108.0k% overvalued
intrinsic discount
1
fair value set
users have set this as their fair value
0
comments
users have commented on this narrative
0
likes
users have liked this narrative
BE
Betsareoff
on PROCEPT BioRobotics
·
Updated
2h ago
PROCEPT BioRobotics sees 17.69% revenue growth and aims for 12.94% profit margin
Fair Value:
US$25.26
29.2% undervalued
intrinsic discount
4
fair values set
users have set this as their fair value
1
comment
users have commented on this narrative
0
likes
users have liked this narrative
Popular Narratives
OS
oscargarcia
on NVIDIA
·
Updated
2mo ago
The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
Fair Value:
US$280
32.1% undervalued
intrinsic discount
2.2k
views
users have viewed this narrative
211
fair values set
users have set this as their fair value
9
comments
users have commented on this narrative
15
likes
users have liked this narrative
CU
CubanEros
on Microsoft
·
Updated
26d ago
A wonderful business at reasonable price.
Fair Value:
US$419.91
7.0% undervalued
intrinsic discount
559
views
users have viewed this narrative
97
fair values set
users have set this as their fair value
0
comments
users have commented on this narrative
7
likes
users have liked this narrative
BE
benjamin_lvieq
on PayPal Holdings
·
Updated
15d ago
PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback
Fair Value:
US$65
10.2% undervalued
intrinsic discount
6.7k
views
users have viewed this narrative
74
fair values set
users have set this as their fair value
2
comments
users have commented on this narrative
11
likes
users have liked this narrative
Trending Discussion
ST
steve_vphrv
on CSL
·
Updated
12h ago
Pretty sure this is analysis of the wrong company. I think this should be against NYSE: CSL not ASX: CSL
1
|
0
BL
Blegells
on Terra Balcanica Resources
·
Updated
1d ago
⏫42X THE AVERAGE DAILY TRADING VOLUME TODAY, JULY 28 🐂🐂🐂 FORTY-TWO!
1
|
0
DE
derek_3wsdg
on Teladoc Health
·
Updated
5d ago
You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.
1
|
0
Value any company in seconds
Popular companies